EGFR and non-small cell lung carcinoma: For example, BE4max was used to precisely introduce the EGFR L858R mutation in non-small cell lung cancer (NSCLC), successfully mimic the clinical resistance phenotype and screen for small molecule inhibitors to reverse the resistance.